Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlaytech Regulatory News (PTEC)

Share Price Information for Playtech (PTEC)

Share Price is delayed by 15 minutes
Get Live Data
308.20    10.80 (3.63%)
Bid:
306.20
Ask:
307.40
Spread: 1.20 (0.392%)
Market Cap: £856.33m
PTEC Live PriceLast checked at - London Stock Exchange

Intraday Playtech Share Chart

FORM 8.3 - PLAYTECH PLC

7 Mar 2022 11:51

Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the β€œCode”)

1. KEY INFORMATION

(a) Full name of discloser:

Barclays PLC.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Β 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PLAYTECH PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Β 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

04 March 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state β€œN/A”

NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Ordinary NPV
InterestsShort Positions
Number(%)Number(%)

(1)

Relevant securities owned

Β 

and/or controlled:

5,134,256

1.68%

3,800,936

1.24%

Β 

Β 

Β 

Β 

Β 

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

3,746,938

1.22%

4,635,474

1.51%

Β 

Β 

Β 

Β 

Β 

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

(4)

Β 

Β 

Β 

Β 

TOTAL:

8,881,194

2.90%

8,436,410

2.75%

Β 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevantPurchase/saleNumber ofPrice per unit
securitysecurities
Ordinary NPVPurchase

83

5.9343 GBP
Ordinary NPVPurchase

300

5.9618 GBP
Ordinary NPVPurchase

300

5.9097 GBP
Ordinary NPVPurchase

521

5.9300 GBP
Ordinary NPVPurchase

585

5.8975 GBP
Ordinary NPVPurchase

750

5.9350 GBP
Ordinary NPVPurchase

915

5.9600 GBP
Ordinary NPVPurchase

949

5.9501 GBP
Ordinary NPVPurchase

1,500

5.9762 GBP
Ordinary NPVPurchase

1,555

5.9603 GBP
Ordinary NPVPurchase

2,028

5.9417 GBP
Ordinary NPVPurchase

2,149

5.9855 GBP
Ordinary NPVPurchase

2,324

5.9829 GBP
Ordinary NPVPurchase

6,032

5.9933 GBP
Ordinary NPVPurchase

8,638

5.9986 GBP
Ordinary NPVPurchase

20,140

5.8814 GBP
Ordinary NPVSale

257

5.9705 GBP
Ordinary NPVSale

312

5.9381 GBP
Ordinary NPVSale

353

5.8552 GBP
Ordinary NPVSale

470

5.9700 GBP
Ordinary NPVSale

585

5.8975 GBP
Ordinary NPVSale

585

5.8976 GBP
Ordinary NPVSale

771

5.8550 GBP
Ordinary NPVSale

910

5.9281 GBP
Ordinary NPVSale

1,243

5.9781 GBP
Ordinary NPVSale

1,250

5.9800 GBP
Ordinary NPVSale

1,278

6.0050 GBP
Ordinary NPVSale

1,685

5.9333 GBP
Ordinary NPVSale

1,775

5.9343 GBP
Ordinary NPVSale

1,859

5.9861 GBP
Ordinary NPVSale

2,418

5.9818 GBP
Ordinary NPVSale

3,029

5.9479 GBP
Ordinary NPVSale

7,360

5.9975 GBP
Ordinary NPVSale

7,615

5.8945 GBP
Ordinary NPVSale

16,192

5.9633 GBP
Ordinary NPVSale

32,460

5.9657 GBP

(b) Cash-settled derivative transactions

Class ofProductNature of dealingNumber ofPrice per
relevantdescriptionreferenceunit
securitysecurities
Ordinary NPVSWAPLong

29

5.9549 GBP
Ordinary NPVSWAPLong

32

6.1400 GBP
Ordinary NPVCFDLong

48

5.9141 GBP
Ordinary NPVCFDLong

81

6.1395 GBP
Ordinary NPVSWAPLong

283

5.9364 GBP
Ordinary NPVSWAPLong

1,775

5.9344 GBP
Ordinary NPVCFDLong

11,687

5.9142 GBP
Ordinary NPVCFDLong

12,923

5.9472 GBP
Ordinary NPVSWAPLong

16,663

5.9673 GBP
Ordinary NPVSWAPLong

24,306

5.9717 GBP
Ordinary NPVSWAPShort

2,324

5.9829 GBP
Ordinary NPVSWAPShort

3,038

5.9570 GBP
Ordinary NPVSWAPShort

6,032

5.9933 GBP
Ordinary NPVSWAPShort

8,919

5.8923 GBP
Ordinary NPVSWAPShort

12,187

5.8850 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state β€œnone”

Β 

None

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state β€œnone”

Β 

None

Β 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

7 March 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number*:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220307005491/en/

Copyright Business Wire 2022

Date   Source Headline
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:46 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSChange of Registered Office
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSCommencement of Share Buyback Programme
11th Sep 20257:00 amRNSInterim Results
4th Aug 20258:00 amRNSNotification and public disclosure of transactions
1st Aug 20257:00 amRNSTrading Update & Notice of Interim Results
13th Jun 20253:30 pmRNSDirector/PDMR Shareholding
5th Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSDividend Currency Election
28th May 20257:00 amRNSAgreement reached regarding German HAPPYBET assets
21st May 20252:08 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Trading Update
13th May 20259:00 amRNSDirector/PDMR Shareholding
2nd May 20257:00 amRNSRemaining redemption of €350 million bond
30th Apr 20253:30 pmRNSReturn of approximately €1.8bn to shareholders
30th Apr 20251:45 pmRNSCompletion of Snaitech sale
25th Apr 20254:46 pmRNSDirector/PDMR Shareholding
25th Apr 20252:05 pmRNSNotice of AGM
16th Apr 20257:00 amRNSAppointment of NED and Chairman Elect
9th Apr 20254:30 pmRNSUpdate on Snaitech Sale
1st Apr 20257:00 amRNSCompletion of revised Caliplay strategic agreement
27th Mar 20257:00 amRNSFinal Results
21st Mar 20254:30 pmRNSUpdate on revised Caliplay strategic agreement
11th Mar 20252:00 pmRNSNotice of Results
19th Feb 20255:00 pmRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSChair succession plan and Board changes
23rd Jan 20253:26 pmRNSDirector/PDMR Shareholding
20th Dec 20243:23 pmRNSPDMR Transaction Notification
19th Dec 20242:00 pmRNSResults of General Meeting
13th Dec 20245:00 pmRNSPDMR Transaction Notification
12th Dec 20245:00 pmRNSPDMR Transaction Notification
27th Nov 20249:00 amRNSPublication of Circular and Notice of GM
26th Nov 20244:30 pmRNSDirectorate Change
22nd Nov 20247:00 amRNSPartial early redemption of €350 million bond
10th Oct 20245:00 pmRNSDirector/PDMR Shareholding
8th Oct 20245:00 pmRNSDirector/PDMR Shareholding
4th Oct 20245:15 pmRNSDirector/PDMR Shareholding
2nd Oct 202411:00 amRNSDirector/PDMR Shareholding
30th Sep 20242:00 pmRNSReplacement Interim Results
30th Sep 20247:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.